Skip to main content

Peer Review reports

From: Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

Original Submission
21 Sep 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
22 Dec 2014 Editorially accepted
27 Jan 2015 Article published 10.1186/s13063-014-0541-9

You can find further information about peer review here.

Back to article page